MedTrace Logo

Effect of 15% Eflornithine Hydrochloride Cream on African-American Males With Pseudofolliculitis Barbae

NCT00176995 · Status: COMPLETED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 15

Last updated 2006-11-13

No results posted yet for this study

Summary

This trial is designed to gain insight into the mechanism of action of eflornithine hydrochloride in men and to aid in determining if this compound is deserving of further development for a pseudofolliculitis barbae indication. This study will also provide knowledge which will be useful in designing future PFB trials in this indication is pursued.

Conditions

  • Pseudofolliculitis Barbae

Interventions

DRUG

15% Eflornithine Hdyrochloride

Sponsors & Collaborators

  • Hordinsky, Maria K., MD

    lead INDIV

Principal Investigators

  • Maria Hordinsky, MD · University of Minnesota

  • Marna Ericson, Ph D · University of Minnesota

Study Design

Allocation
NON_RANDOMIZED
Purpose
ECT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
MALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
1999-03-31
Completion
2000-10-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00176995 on ClinicalTrials.gov